MedPath

A Prospective Phase 1 Study of a Novel Bi-Directional Arterial Cannula in Patients requiring Peripheral Veno-Arterial Extra Corporeal Membrane Oxygenation (VA-ECMO) Support.

Phase 1
Conditions
Patients who require peripheral cannulation for Veno-Arterial Extra Corporeal Membrane Oxygenation.
Heart Failure
Cardiovascular - Coronary heart disease
Registration Number
ACTRN12615001086550
Lead Sponsor
The Alfred Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

1.Must be between18 years and 80 years inclusive.
2. Assessed as requiring V-A ECMO support by ICU consultant
3. Must weigh between 45kg and 130kg inclusive.
4. Site personel must obtain written informed consent from the patient or their legally authorised representative prior to any study procedures

Exclusion Criteria

Patients with a history of peripheral vascular disease
-previous peripheral arterial bypass
-diabetic vasculopathy
2. Patients with a history of diabetic retinopathy
3. Patients with a history of diabetic nephropathy
4. Patients where the common femoral artery is not identifiable with vascular ultrasound.
5. Patients where the common femoral artery is identifiable with vascular ultrasound but the internal diameter of the femoral artery is not greater than 0.6cm.
6.Patients requiring ECMO support to be instituted in the emergency setting during Cardio Pulmonary Resuscitation (CPR).
7. Non Alfred Hospital VA ECMO initiation (retrieval)
8. Concurrent enrolment in another investigational drug or device study, or use of any experimental or investigational drug or device within 30 days of ECMO support.
9. Any other medical condition which in the view of the investigator is likely to interfere with the study or put the participant at risk.
10. Patients who the investigator feels may not achieve adequate flow rates and line pressures due to their weight or body height.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath